Post-earnings recap
Reported
Wed, Nov 8, 2017
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Axsome Therapeutics reported a loss of $0.27 per share, but did not provide revenue figures or guidance. The stock reacted negatively, declining by 5.15%. Investors may be concerned about the lack of updates and clarity on the company's future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.27 | N/A | — |
| Revenue | — | N/A | — |
No transcript is on record for the earnings call, and the analysis is based solely on numerical results.